External Funding

We are proud to support patient groups, academic research institutions, industry associations and other partners as part of our mission to transform patients’ lives.

As a Novartis Company, Advanced Accelerator Applications may provide external funding to legitimate organizations in the interest of driving its mission to improve healthcare, advance scientific/medical knowledge or support the communities where associates live and work.

We ensure that our interactions with all of our stakeholders are based on the highest ethical standards and compliant with all applicable laws, regulations and industry codes and we strive to build relationships based on transparency, mutual respect and shared goals.

For information on Advanced Accelerator Applications UK Patient Group Partnering and Joint Working Initiatives, please click here.

Applying for funding

Applications must outline a clear and defined purpose and transparent objectives, deliverables, milestones and outcomes as appropriate and directly related to Advanced Accelerator Applications Areas of Interest.

Applications will only be accepted from legitimate organizations and not to individuals. The applicant will be responsible for the application, content and implementation of any activity that receives support, including compliance with laws and regulations.

Grants

Funding may be provided in the form of grants. A grant is an unsolicited, independently requested monetary contribution for a specified purpose to support medical/scientific research, education, policy initiatives, and patient advocacy activities. Grants will not be provided to political parties. Please note that an Investigator Initiated Trial (IIT) or study funding request is not to be considered as a grant.

For more information regarding IITs, please click here.

How do I submit a grant request?

For all countries except for the United States of America (“ex-US”), grant applications are only received through the Novartis GEMS (Grants, External Studies and Managed Access System) Portal by clicking here: Submit a grant request (ex-US). Sponsorship requests for all countries except for the United States of America (“ex-US”), may be directed to appropriate Advanced Accelerator Applications contacts.

To submit a medical grant, or patient advocacy sponsorship or grant application in the United States of America (US), please click here to access the US country page and see specific information for medical or patient advocacy funding requests. Any other US sponsorship requests should be directed to appropriate Advanced Accelerator Applications contacts.

Guidance on using the GEMS Portal is available here:

Introduction to Novartis GEMS Portal for Grant Application (PDF 0.2 MB)

Novartis GEMS Portal for Grants step-by-step user guide (PDF 1.8 MB)

How are grant applications evaluated?

Once received, each request will be reviewed carefully and fairly by the appropriate  experts with every effort made to provide a response once we have all the necessary information.

Please note that your request will be assessed in consideration of applicable local laws and regulations.

We inform you that the personal data you provide by sending this e-mail will be processed in compliance with ARTICLES 13 AND 14 OF REGULATION (EU) 2016/679 (GDPR) as referred to in the privacy policy on our website and which recalls the confidentiality obligations that inspire our company’s activity in order to be able to respond quickly and comprehensively to your request.

The processing of your personal data will be carried out using appropriate tools to ensure the security and confidentiality of the aforementioned data.

The methods of processing of data referred in this notice to here provide for applies for the use of manual, computerized and telematic tools.

Your data will be processed by employees and / or collaborators of Advanced Accelerator Applications  duly appointed for processing. Furthermore, Advanced Accelerator Applications  is part of a multinational Group, therefore it may be that your personal data are transferred to other countries, even outside the European Union, to parent companies, subsidiaries or affiliates, as well as to external service companies, even if only for technical-IT reasons. In these cases we will proceed to their transfer only in the presence of the provision of your consent.

The optional, explicit and voluntary sending of e-mail address or other data entered in the contact form to the official addresses indicated on this site entails the subsequent acquisition of the sender’s e-mail address necessary to respond to requests, as well as any other personal data entered. Specific summary information could be progressively reported or displayed on the pages of the website prepared for particular services on request.

The user confers the widest indemnity with respect to any objection, claim request for compensation for damage from treatment that should be received by the Data Controller from any third party concerned due to the provision of data indicated by the user in violation of the rules on protection of the personal data applicable according to the GDPR 2016/679.

THE REGULATION (EU) 2016/679 includes measures to protect and guarantee your rights, in particular, the interested party has the right at any time to obtain confirmation of the existence of personal data concerning him/her and to know its content and origin, verify its accuracy or request its integration or updating, or rectification. It also has the right to request the cancellation, transformation into anonymous form or blocking of data processed in violation of the law, as well as to oppose in any case, for legitimate reasons, to their processing. You may exercise these rights at any time by contacting us at: dpo@staging.newadacap.supremeoptistage.com.

To get more information about the website Privacy Policy, CLICK HERE.

    149803   8/21